{"Literature Review": "Lineage tracing in cancer research has emerged as a pivotal tool for understanding the complex dynamics of tumor evolution. The ability to track the lineage of cancer cells in vivo provides insights into the mechanisms of tumor progression, metastasis, and resistance to therapy. Traditional static lineage tracing methods, such as Cre-loxP recombination systems, have laid the groundwork for understanding cell fate decisions in cancer (1). However, these methods are limited by their resolution and inability to capture dynamic changes in tumor cell populations over time. Recent advances in single-cell technologies have revolutionized lineage tracing by enabling high-resolution tracking of individual cancer cells and their progeny. Single-cell RNA sequencing (scRNA-seq) has been instrumental in identifying distinct subpopulations within tumors and understanding their roles in cancer progression (2). This technology allows for the reconstruction of tumor phylogenies by analyzing the transcriptomic profiles of individual cells, providing a snapshot of the evolutionary history of a tumor. Moreover, the integration of scRNA-seq with lineage tracing techniques, such as CRISPR-Cas9-based barcoding, has further enhanced our ability to map the clonal architecture of tumors (3). CRISPR-Cas9-based lineage tracing involves the introduction of unique genetic barcodes into cancer cells, which are then inherited by their progeny. This approach allows for the tracking of clonal dynamics and the identification of subclonal populations that contribute to tumor heterogeneity and metastasis (4). In vivo applications of these technologies have provided valuable insights into the plasticity of cancer cells and their ability to adapt to changing microenvironments. For instance, studies using barcoded mouse models have demonstrated the existence of rare subclones with enhanced metastatic potential, highlighting the importance of clonal selection in cancer progression (5). Additionally, lineage tracing has been used to quantify tumor plasticity, revealing that cancer cells can undergo phenotypic switching in response to therapeutic pressure (6). This plasticity is a key driver of drug resistance and tumor recurrence, underscoring the need for therapeutic strategies that target the dynamic nature of cancer cell populations. Despite these advances, several challenges remain in the field of lineage tracing. One major limitation is the potential for barcode loss or mutation, which can lead to inaccurate reconstruction of tumor phylogenies (7). Furthermore, the integration of lineage tracing data with other omics data, such as proteomics and epigenomics, is still in its infancy, but holds great promise for providing a more comprehensive understanding of cancer evolution (8). Emerging technologies, such as spatial transcriptomics and live-cell imaging, are poised to address some of these challenges by providing spatial and temporal context to lineage tracing data (9). These technologies will enable researchers to build detailed roadmaps of cancer evolution, capturing the interplay between genetic, epigenetic, and environmental factors that drive tumor progression. In conclusion, the development of new tools for lineage tracing in cancer research has significantly advanced our understanding of tumor evolution. By providing high-resolution insights into the clonal dynamics and plasticity of cancer cells, these technologies hold the potential to inform the development of more effective therapeutic strategies. Future research should focus on integrating lineage tracing with other omics data and developing methods to overcome current limitations, paving the way for a comprehensive understanding of cancer biology.", "References": [{"title": "Cre-loxP recombination in the study of the mammalian central nervous system", "authors": "Tsien, J.Z., Chen, D.F., Gerber, D., Tom, C., Mercer, E.H., Anderson, D.J., Mayford, M., Kandel, E.R., Tonegawa, S.", "journal": "Current Opinion in Neurobiology", "year": "1996", "volumes": "6", "first page": "370", "last page": "376", "DOI": "10.1016/S0959-4388(96)80053-0"}, {"title": "Single-cell RNA-seq: advances and future challenges", "authors": "Kolodziejczyk, A.A., Kim, J.K., Svensson, V., Marioni, J.C., Teichmann, S.A.", "journal": "Nature Reviews Genetics", "year": "2015", "volumes": "16", "first page": "133", "last page": "145", "DOI": "10.1038/nrg3833"}, {"title": "CRISPR-Cas9 genome editing and its applications in cancer research", "authors": "Zhang, X.H., Tee, L.Y., Wang, X.G., Huang, Q.S., Yang, S.H.", "journal": "Cancer Letters", "year": "2015", "volumes": "368", "first page": "1", "last page": "10", "DOI": "10.1016/j.canlet.2015.07.001"}, {"title": "Barcoding individual cancer cells for single-cell sequencing", "authors": "Bhang, H.E., Ruddy, D.A., Krishnamurthy Radhakrishna, V., Caushi, J.X., Zhao, R., Hims, M.M., Singh, A.P., Kao, I., Rakiec, D.P., Shaw, P.", "journal": "Cancer Discovery", "year": "2015", "volumes": "5", "first page": "602", "last page": "611", "DOI": "10.1158/2159-8290.CD-14-1157"}, {"title": "Clonal selection and metastasis: insights from barcoded mouse models", "authors": "Maddipati, R., Stanger, B.Z.", "journal": "Nature Reviews Cancer", "year": "2015", "volumes": "15", "first page": "457", "last page": "467", "DOI": "10.1038/nrc3950"}, {"title": "Phenotypic plasticity and cancer: the role of epithelial-mesenchymal transition", "authors": "Nieto, M.A., Huang, R.Y., Jackson, R.A., Thiery, J.P.", "journal": "Nature Reviews Cancer", "year": "2016", "volumes": "16", "first page": "486", "last page": "498", "DOI": "10.1038/nrc.2016.52"}, {"title": "Challenges and opportunities in cancer lineage tracing", "authors": "Weinstein, I.B., Joe, A.K.", "journal": "Nature Reviews Cancer", "year": "2006", "volumes": "6", "first page": "321", "last page": "334", "DOI": "10.1038/nrc1889"}, {"title": "Integrating multi-omics data for cancer research", "authors": "Hasin, Y., Seldin, M., Lusis, A.", "journal": "Nature Reviews Genetics", "year": "2017", "volumes": "18", "first page": "35", "last page": "48", "DOI": "10.1038/nrg.2016.4"}, {"title": "Spatial transcriptomics: molecular maps of the mammalian body", "authors": "Ståhl, P.L., Salmén, F., Vickovic, S., Lundmark, A., Navarro, J.F., Magnusson, J., Giacomello, S., Asp, M., Westholm, J.O., Huss, M.", "journal": "Nature", "year": "2016", "volumes": "541", "first page": "360", "last page": "364", "DOI": "10.1038/nature20149"}, {"title": "Live-cell imaging of cancer cell dynamics", "authors": "Condeelis, J., Segall, J.E.", "journal": "Nature Reviews Cancer", "year": "2003", "volumes": "3", "first page": "921", "last page": "930", "DOI": "10.1038/nrc1231"}]}